Okay. Before I leave that area, I'm curious about your comment on one aspect of this. Remdesivir, which is the first drug approved by licensing authorities in the U.S. to treat COVID-19, is made by Gilead, and that's been shown to help people recover faster from the disease. The first 140,000 doses supplied to drug trials around the world have been used up, and we now see that the Trump administration has now bought more than 500,000 doses, which is all of Gilead's production for July, and 90% of it for August and September.
In your view, should Canada issue compulsory licences in order to secure a sufficient domestic supply of COVID-19 treatments like remdesivir?